Psychedelic Medicine

Psychedelic Investing For Beginners: Seize The Golden Moment!

Honoring Johns Hopkins Psychedelic Pioneer Dr. Roland Griffiths And His Legacy In Healing Minds

Psychedelic Medicine Coalition CEO Melissa Lavasani On Psychedelics Advocacy On Capitol Hill

Honoring Johns Hopkins Psychedelic Pioneer Dr. Roland Griffiths And His Legacy In Healing Minds

Psychedelic Medicine Coalition CEO Melissa Lavasani On Psychedelics Advocacy On Capitol Hill

Canadian Government Granting $3M For Clinical Trials For Psilocybin-Assisted Psychotherapy

Zappy Zapolin Believes Psychedelic Research Has Come Of Age

Canadian Government Granting $3M For Clinical Trials For Psilocybin-Assisted Psychotherapy

Zappy Zapolin Believes Psychedelic Research Has Come Of Age

Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market

Novamind Stock Dives On $3.95M Private Placement With Institutional Investor

Psychedelic Medicine Recent News

Mydecine: Q3 Financials, Advances Research On Psychedelic Therapies For Mental Health & Addiction Disorders

Mydecine Innovations Group (NEO:MYCO) (OTC: MYCOF) (FSE:0NFA) reported its financial results on Tuesday and provided a business update for the third quarter ended September 30.

Psychedelics Stock MindMed Skyrockets On The News Of Nasdaq Trading

Mind Medicine Inc. (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ) confirmed Monday it will commence trading on the Nasdaq Capital Market under the ticker symbol “MNMD” on April 27th.

MindMed Reveals Results Of A Study On Personalized MDMA Dosing

Psychedelic medicine biotech company MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ) reported Monday the results of a study on MDMA dosing optimization utilizing perso